Abstract
The adherence of 27 clinical Pseudomonas aeruginosa strains to collagen type I was investigated by using a solid-phase assay. The influence of free antibiotics (amikacin, gentamicin, piperacillin, bacitracin, and polymyxin B) and liposome-entrapped antibiotics (amikacin and polymyxin B) on bacterial attachment to collagen type I was examined. The greatest inhibitory effect was shown for free and liposomal amikacin, which decreased the attachment of 74 and 100% of tested strains, respectively. The mean percent attachment (+/- standard deviation) in the presence of free amikacin was 65.7% (+/- 12.0%) as measured by solid-phase assay. In the presence of liposomal amikacin, the attachment ranged from 17.3% (+/- 6.0%) to 42.1% (+/- 9.4%), depending on the antibiotic solvent. In contrast, polymyxin B, even at a subinhibitory concentration, enhanced attachment of all P. aeruginosa isolates to collagen. Liposomal polymyxin B displayed a protective effect only when the encapsulated drug was of a low concentration. Application of liposome-encapsulated amikacin may be advantageous in injured tissues in which extracellular matrix structures become exposed.
References
Oct 1, 1976·Immunochemistry·D C Morrison, D M Jacobs
Aug 1, 1992·Infection and Immunity·M Sexton, D J Reen
Jun 1, 1991·The Journal of Clinical Investigation·M C PlotkowskiE Puchelle
Oct 1, 1989·Antimicrobial Agents and Chemotherapy·R S Conrad, C Galanos
May 1, 1988·Infection·A Coune
Oct 1, 1988·Journal of Microencapsulation·M C NacucchioM D'Aquino
Jan 1, 1988·The Journal of Infectious Diseases·K H SchadowG D Christensen
May 20, 1981·Biochimica Et Biophysica Acta·F Sixl, H J Galla
Jan 1, 1993·Drugs·G Gregoriadis, A T Florence
Dec 1, 1994·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·G Piatti
Jan 1, 1994·Microbiology and Immunology·T Umemoto, I Namikawa
Feb 1, 1995·Acta Orthopaedica Scandinavica·P Riegels-NielsenN Frimodt-Møller
Jan 1, 1995·The Journal of Antibiotics·C M MorrisF R Champlin
Aug 1, 1993·Molecular Microbiology·B Westerlund, T K Korhonen
Feb 1, 1994·The Journal of Clinical Investigation·R D Isaacs
Mar 1, 1994·Chemotherapy·W G ButcherL M Switalski
May 1, 1994·Infection and Immunity·Q ZhangR F Ross
Sep 1, 1993·Antimicrobial Agents and Chemotherapy·S T BoyceI A Holder
Feb 1, 1994·Infection and Immunity·S Girod de BentzmannE Puchelle
Sep 1, 1993·Journal of Bacteriology·J L KadurugamuwaT J Beveridge
Oct 1, 1993·Infection and Immunity·G T MaiY H Thong
Citations
Aug 11, 1998·Journal of Biomedical Materials Research·E A TrafnyJ Grzybowski
Mar 17, 2004·Biomaterials·Si-Nae ParkHwal Suh
Jan 18, 2003·Journal of Microbiological Methods·Britta SwansonJeanine Wiener-Kronish
Dec 1, 1998·International Journal of Antimicrobial Agents·E A Trafny
Sep 3, 2003·Biological & Pharmaceutical Bulletin·Takashi KitaharaHitoshi Sasaki
Nov 26, 2013·Future Microbiology·Sarah Elizabeth MaddocksRose Agnes Cooper
Aug 20, 2014·Expert Opinion on Drug Delivery·Ahmed A AbdelazizGamal M El Maghraby
Dec 30, 2014·Journal of Pharmaceutical Sciences·Rahul S KalhapureThirumala Govender
Dec 9, 2009·International Journal of Pharmaceutics·Zuzanna Drulis-Kawa, Agata Dorotkiewicz-Jach
May 26, 2006·International Wound Journal·Masahiro TachiPhilip Bowler
Jul 27, 1999·Journal of Microencapsulation·E A TrafnyJ Grzybowski
Jun 8, 2014·Colloids and Surfaces. B, Biointerfaces·L TavanoL Pérez
Apr 17, 2014·Pathogens and Disease·Aurélie CrabbéCheryl A Nickerson
Nov 6, 2004·Chemotherapy·Laurent Bret, Patrick Di Martino
Aug 18, 2004·Journal of Medical Microbiology·A P FonsecaJ C Sousa
Oct 16, 2004·The Journal of Antimicrobial Chemotherapy·Ashraf A KadryMohsen A Bayomi
Sep 14, 2017·Frontiers in Microbiology·Shahper N KhanAsad U Khan